Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

After a healthcare professional has shown you how to inject Ozempic correctly, you may be able to give yourself the injections at home ... drug in the medication Wegovy. And Wegovy is approved ...

When combined with humidity, the mix can make it dangerous to work and ... and diabetic and obesity medications such as Ozempic and Wegovy. “The Ozempic and Wegovy medications are proteins ...

It’s a mix of the songs that I’ve been listening ... Patients taking the obesity drug Wegovy were less likely to die from Covid, a large clinical trial found. The result surprised and excited ...

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...

This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the ...

Results from a new study showed people taking Wegovy (semaglutide) for weight loss were 33 percent less likely to die of COVID-19 than people taking placebo. They were also 15 percent less likely ...

The experimental medication has the potential to reduce hunger and slow stomach emptying even more so than drugs that are already on the market to treat obesity, like Wegovy. Novo Nordisk ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new formulation ...

Lauren Ball works for The University of Queensland and receives funding from the National Health and Medical Research Council, Queensland Health and Mater Misericordia. She is a Director of ...

Novo Nordisk’s oral obesity pill, amycretin, showed faster weight loss than its blockbuster weekly injection for chronic weight management, Wegovy (semaglutide), in the phase I study.